“COVID-19 Q&A Webinar for Laboratory Accreditation”
Event Navigation
The Joint Commission* presents... “COVID-19 Q&A Webinar for Laboratory Accreditation”
The Joint Commission hosts a live question and answer session relevant to the public health emergency. Topics to be covered include:
- Infection control practices
- Environment of care/life safety
- CMS 1135 waivers
- Effects of COVID-19 on Joint Commission survey efforts
Presenters:
- Robert Campbell, PharmD, BCSCP | Director, Clinical Standards Interpretation Hospital/Ambulatory Programs | Director, Medication Management | The Joint Commission
- Sylvia Garcia-Houchins, MBA, RN, CIC | Director | Infection Prevention and Control | The Joint Commission
- Bridget Kapnick, MPH | Associate Director, Accreditation | Accreditation and Certification Operations | The Joint Commission
- Herman A. McKenzie, MBA, CHSP | Director of Engineering | Standards Interpretation Group | The Joint Commission
- Maura Naddy, MSN, RNC-OB, CJCP | Associate Director | Standards Interpretation Group | The Joint Commission
- Amy Null | Surveyor | Laboratory Accreditation Program | The Joint Commission
- Barbara Schwarzer, MHA, MSOL, MT(ASCP), CPHQ | Field Director | The Joint Commission
- Cherie Ulaskas, MT(ASCP), MA | Associate Director | Standards Interpretation Group | The Joint Commission
- Tiffany Wiksten, MSN, RN, CIC | Associate Director | Standards Interpretation Group | The Joint Commission
Target Audience: Anyone interested
It does not appear CE credit is associated with this session.
Questions should be directed to the Joint Commission at 630.792.5291; certification@jointcommission.org
* NOTE: This is an industry-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products, services, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier, product, service, drug, brand or approach.
